Concord Biotech Limited — Important, 12-06-2026: Updates
12-06-2026 | 01:35 pm
12-06-2026 | 01:35 pm
Concord Biotech successfully completed an ANVISA inspection at its Limbasi API facility. This strengthens its global manufacturing footprint, advancing international expansion and enhancing access to major pharmaceutical markets like Brazil, broadening the reach of its high-quality APIs.
No comments yet. Be the first to comment!
